Sanada Satoru, Katano Saki, Asami Kengo, Kumata Hiroyuki, Sekiguchi Satoshi, Sato Mitsuhiro
Division of Nephrology, Japan Community Health Care Organization Sendai Hospital, 2-1-1, Murasakiyama, Izumi, Sendai, Miyagi, Japan.
Division of Surgery, Japan Community Health Care Organization Sendai Hospital, Sendai, Miyagi, Japan.
Sci Rep. 2025 Jul 21;15(1):26466. doi: 10.1038/s41598-025-11292-4.
Tonicity-responsive enhancer binding protein (TonEBP) protects kidney tubular cells against hypertonicity. Calcineurin inhibitors (CNI) are known to suppress TonEBP by hampering nuclear translocation. Moreover, sodium inversely activates TonEBP. We investigated whether CNI-induced nephrotoxicity in transplant recipients could be due to impaired TonEBP activity, and whether sodium restriction exacerbates the intoxication. Immunohistochemical analysis using biopsy specimens from 128 patients revealed that TonEBP was mainly located in the cytoplasm in cases of CNI nephrotoxicity, while it showed nuclear-cytoplasmic staining in cases of rejection or interstitial fibrosis and tubular atrophy. This suggests that TonEBP transactivation is limited in CNI nephrotoxicity. A retrospective observational analysis of 308 kidney transplant recipients at our institute between 1984 and 2018 showed a positive correlation between dietary salt intake and eGFR slope. A low-salt diet is linked to a rapid annual decline in eGFR, with adjusted odds ratios of 2.40 and a 95% confidence interval of 1.18-4.90. These findings suggest that the recommended salt intake for kidney transplant recipients may require reassessment.
渗透压反应增强子结合蛋白(TonEBP)可保护肾小管细胞免受高渗影响。已知钙调神经磷酸酶抑制剂(CNI)通过阻碍核转位来抑制TonEBP。此外,钠可反向激活TonEBP。我们研究了移植受者中CNI诱导的肾毒性是否可能归因于TonEBP活性受损,以及限钠是否会加重中毒。对128例患者的活检标本进行免疫组织化学分析显示,在CNI肾毒性病例中,TonEBP主要位于细胞质中,而在排斥反应或间质纤维化及肾小管萎缩病例中,它表现为核质染色。这表明在CNI肾毒性中,TonEBP反式激活受到限制。对我院1984年至2018年间308例肾移植受者的回顾性观察分析显示,饮食盐摄入量与估算肾小球滤过率(eGFR)斜率呈正相关。低盐饮食与eGFR的快速年度下降有关,校正比值比为2.40,95%置信区间为1.18 - 4.90。这些发现表明,可能需要重新评估肾移植受者的推荐盐摄入量。